The groundbreaking treatment of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide363538.blogoxo.com/42409065/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment